Suppr超能文献

人源蛋白激酶前口袋 N 端帽半胱氨酸的反应活性。

Reactivities of the Front Pocket N-Terminal Cap Cysteines in Human Kinases.

机构信息

Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, United States.

Discovery Sciences, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States.

出版信息

J Med Chem. 2022 Jan 27;65(2):1525-1535. doi: 10.1021/acs.jmedchem.1c01186. Epub 2021 Oct 14.

Abstract

The front pocket (FP) N-terminal cap (Ncap) cysteine is the most popular site of covalent modification in kinases. A long-standing hypothesis associates the Ncap position with cysteine hyper-reactivity; however, traditional computational predictions suggest that the FP Ncap cysteines are predominantly unreactive. Here we applied the state-of-the-art continuous constant pH molecular dynamics (CpHMD) to test the Ncap hypothesis. Simulations found that the Ncap cysteines of BTK/BMX/TEC/ITK/TXK, JAK3, and MKK7 are reactive to varying degrees; however, those of BLK and EGFR/ERBB2/ERBB4 possessing a Ncap+3 aspartate are unreactive. Analysis suggested that hydrogen bonding and electrostatic interactions drive the reactivity, and their absence renders the Ncap cysteine unreactive. To further test the Ncap hypothesis, we examined the FP Ncap+2 cysteines in JNK1/JNK2/JNK3 and CASK. Our work offers a systematic understanding of the cysteine structure-reactivity relationship and illustrates the use of CpHMD to differentiate cysteines toward the design of targeted covalent inhibitors with reduced chemical reactivities.

摘要

前口袋 (FP) N 端帽 (Ncap) 半胱氨酸是激酶中最常见的共价修饰位点。一个长期存在的假说将 Ncap 位置与半胱氨酸的高反应性联系起来;然而,传统的计算预测表明 FP Ncap 半胱氨酸主要是无反应的。在这里,我们应用最先进的连续恒 pH 分子动力学 (CpHMD) 来测试 Ncap 假说。模拟发现 BTK/BMX/TEC/ITK/TXK、JAK3 和 MKK7 的 Ncap 半胱氨酸具有不同程度的反应性;然而,那些具有 Ncap+3 天冬氨酸的 BLK 和 EGFR/ERBB2/ERBB4 则没有反应性。分析表明,氢键和静电相互作用驱动反应性,而它们的缺失使 Ncap 半胱氨酸无反应性。为了进一步验证 Ncap 假说,我们检查了 JNK1/JNK2/JNK3 和 CASK 中的 FP Ncap+2 半胱氨酸。我们的工作提供了对半胱氨酸结构-反应性关系的系统理解,并说明了如何使用 CpHMD 来区分半胱氨酸,从而设计具有降低化学反应性的靶向共价抑制剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f135/8812259/4c0bfe7d2a7f/nihms-1772347-f0002.jpg

相似文献

1
3
How Reactive are Druggable Cysteines in Protein Kinases?蛋白激酶中可反应的半胱氨酸有多少?
J Chem Inf Model. 2018 Sep 24;58(9):1935-1946. doi: 10.1021/acs.jcim.8b00454. Epub 2018 Aug 29.
7
Abl N-terminal cap stabilization of SH3 domain dynamics.Abl对SH3结构域动力学的N端帽稳定作用。
Biochemistry. 2008 May 27;47(21):5795-803. doi: 10.1021/bi800446b. Epub 2008 May 2.

引用本文的文献

3
Covalent-Allosteric Inhibitors: Do We Get the Best of Both Worlds?共价变构抑制剂:我们能否两全其美?
J Med Chem. 2025 Feb 27;68(4):4040-4052. doi: 10.1021/acs.jmedchem.4c02760. Epub 2025 Feb 12.
5
Force Field Limitations of All-Atom Continuous Constant pH Molecular Dynamics.全原子连续恒 pH 分子动力学的力场限制。
J Phys Chem B. 2024 Nov 28;128(47):11616-11624. doi: 10.1021/acs.jpcb.4c05971. Epub 2024 Nov 12.

本文引用的文献

2
Orelabrutinib: First Approval.奥雷巴替尼:首次获批
Drugs. 2021 Mar;81(4):503-507. doi: 10.1007/s40265-021-01482-5. Epub 2021 Mar 11.
7
Tirabrutinib: First Approval.替拉鲁替尼:首次批准。
Drugs. 2020 Jun;80(8):835-840. doi: 10.1007/s40265-020-01318-8.
9
Advances in covalent kinase inhibitors.共价激酶抑制剂的研究进展。
Chem Soc Rev. 2020 May 7;49(9):2617-2687. doi: 10.1039/c9cs00720b. Epub 2020 Mar 30.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验